Finanzwire Finanzwire
Basculer en Français
10620 Companies
225701 Keywords
154264 Articles
119430 Press releases
Headlines Articles Press releases Vaderis Therapeutics AG Remove
  1. Home
  2. Companies
  3. Vaderis Therapeutics AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/02/2025 at 15:15, 6 months 21 days ago

    Vaderis Therapeutics' Engasertib Studies Published in NEJM

    Clinical Study New England Journal Of Medicine Vaderis Therapeutics Engasertib Hereditary Hemorrhagic Telangiectasia
  • PRESS RELEASE

    published on 12/02/2025 at 15:10, 6 months 21 days ago

    Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia

    Vaderis Therapeutics announces publication of engasertib proof-of-concept study results in The New England Journal of Medicine, showing potential for Hereditary Hemorrhagic Telangiectasia patients
    Proof-of-Concept Study Vaderis Therapeutics Engasertib Hereditary Hemorrhagic Telangiectasia The New England Journal Of Medicine
    Logo of Vaderis Therapeutics AG
Accesswire
  • Published on 06/24/2026 at 03:15, 52 minutes ago

    Noram Lithium Adopts Semi-Annual Financial Reporting

  • Published on 06/24/2026 at 00:00, 4 hours 7 minutes ago

    Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

  • Published on 06/23/2026 at 23:45, 4 hours 22 minutes ago

    Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs

  • Published on 06/23/2026 at 23:20, 4 hours 47 minutes ago

    BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption

  • Published on 06/23/2026 at 23:15, 4 hours 52 minutes ago

    EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects

View all ACCESSWIRE
EQS Group
  • Published on 06/24/2026 at 02:05, 2 hours 2 minutes ago

    FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO

  • Published on 06/23/2026 at 22:20, 5 hours 47 minutes ago

    Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership

  • Published on 06/23/2026 at 20:15, 7 hours 52 minutes ago

    EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights

  • Published on 06/23/2026 at 18:59, 9 hours 8 minutes ago

    Holding(s) in Company

  • Published on 06/23/2026 at 17:55, 10 hours 12 minutes ago

    ABO Energy ABO Energy drives strategic development and future financing solution forward

View all EQS
Les Echos
  • Published on 06/23/2026 at 19:47, 8 hours 20 minutes ago

    GROUPE SFPI: General management reorganisation

  • Published on 06/23/2026 at 19:10, 8 hours 57 minutes ago

    GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026

  • Published on 06/23/2026 at 16:47, 11 hours 20 minutes ago

    Statement of transactions in own shares from June 15, 2026 to June 19, 2026

  • Published on 06/23/2026 at 15:44, 12 hours 23 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026

  • Published on 06/23/2026 at 14:00, 14 hours 7 minutes ago

    Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy